Experimental Pharmacology and New Targets in Cardiopulmonary Disorders

Our research group seeks to delve into the cellular and molecular bases of pulmonary vascular diseases to find new therapeutic targets and strategies. Our research places a special focus on understanding endothelial damage and its connection with vascular smooth muscle and the immune system, all of which are very present in the development of cardiovascular diseases. For this Master research project we offer the possibility to deep investigate into the molecular bases of endothelial dysfunction related to pulmonary arterial hypertension with special focus in how mitochondrial deregulation and metabolic dysfunction is involved and how different drugs can regulate its activity and therefore protect the endothelium.